menu
    • menu

    Company profile for Oxford Biomedica

    NEW Drugs in Dev: 11
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oxford BioMedica (OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. We have built a sector-leading lentiviral vector delivery platform, called LentiVector®, which we use to develop in vivo and ex vivo products both in-house and with partners. We have created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, op...
    Oxford BioMedica (OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. We have built a sector-leading lentiviral vector delivery platform, called LentiVector®, which we use to develop in vivo and ex vivo products both in-house and with partners. We have created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. We also have a number of partnerships, including with Novartis, Sanofi, GSK and Orchard Therapeutics, where we have long-term economic interests in other potential gene and cell therapy

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oxford Biomedicaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Windrush Court Transport Way Oxford OX4 6LT
    Telephone
    Telephone
    +44 (0) 1865 783 000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oxb.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oxford-biomedica/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OxfordBioMedica

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OXB to Exhibit and Present at 30th ASGCT Annual Meeting
    OXB to Exhibit and Present at 30th ASGCT Annual Meeting

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3290979/0/en/oxb-to-exhibit-and-present-at-the-30th-annual-meeting-of-the-american-society-of-cell-and-gene-therapy-asgct.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    OXB Inks Multi-Year Supply Deal With Bristol Myers Squibb
    OXB Inks Multi-Year Supply Deal With Bristol Myers Squibb

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231900/0/en/OXB-Signs-New-Multi-Year-Commercial-Supply-Agreement-with-Bristol-Myers-Squibb.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    CDMO OXB Raises £60M to Support US Expansion Ambitions
    CDMO OXB Raises £60M to Support US Expansion Ambitions

    18 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/cdmo-oxb-raises-ps60m-share-placing-support-us-expansion-ambitions

    FIERCE PHARMA
    18 Aug 2025
    Share Share
    OXB completes acquisition of remaining stake in US subsidiary
    OXB completes acquisition of remaining stake in US subsidiary

    23 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/23/3103252/0/en/OXB-completes-acquisition-of-remaining-stake-in-US-subsidiary.html

    GLOBENEWSWIRE
    23 Jun 2025
    Share Share
    Oxford Biomedica Rebrands As OXB For CDMO Transformation
    Oxford Biomedica Rebrands As OXB For CDMO Transformation

    18 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/18/2948064/0/en/Oxford-Biomedica-rebrands-as-OXB-reinforcing-transformation-into-leading-global-cell-and-gene-therapy-CDMO.html

    GLOBENEWSWIRE
    18 Sep 2024
    Share Share
    Oxford Biomedica Rebrands as OXB
    Oxford Biomedica Rebrands as OXB

    18 Sep 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-09-18/oxford-biomedica-rebrands-as-oxb/?widget=listSection

    CONTRACT PHARMA
    18 Sep 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search